LIMA1 Antikörper (N-Term)
Kurzübersicht für LIMA1 Antikörper (N-Term) (ABIN953171)
Target
Alle LIMA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 134-163, N-Term
-
Spezifität
- This antibody recognizes Human LIMA1 (N-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 134-163 amino acids from the N-terminal region of human LIMA1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LIMA1 (LIM Domain and Actin Binding 1 (LIMA1))
-
Andere Bezeichnung
- LIMA1
-
Hintergrund
- EPLIN is a cytoskeleton-associated protein that inhibits actin filament depolymerization and cross-links filaments in bundles (Maul et al., 2003 [PubMed 12566430]).Synonyms: EPLIN, Epithelial protein lost in neoplasm, LIM domain and actin-binding protein 1, LIMA1, SREBP3
-
Molekulargewicht
- 85226 Da
-
Gen-ID
- 51474
-
NCBI Accession
- NP_001107018
Target
-